IsomAb (private company)
See something wrong or missing? Let us know
Offices:Nottingham
Industry:Health servicesManufacturingPharma
Business model:B2B
IsomAb is a British pharma research startup focused on treating peripheral arterial disease (PAD) as it developed an antibody that inhibits the effects of the protein and allows new blood vessels to be created.
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 9.53M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain